Asher Biotherapeutics’ $108 Million Series B Financing

Goodwin Procter advised Asher Biotherapeutics on the deal.Asher Biotherapeutics announced the closing of its Series B financing, which raised $108 million. The financing was led by Wellington…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now